FundedIQ
Biotechnology

Koya Medical: Funding, Investors & Team (Sep 2026)

Koya Medical is an innovative healthcare organization dedicated to advancing the treatment of venous and lymphatic diseases. By offering revolutionary therapies, we aim to enhance movement, mobility, and personalized care, surpassing what traditional compression therapy can provide. Established in 2018, Koya is committed to revolutionizing venous and lymphatic care through patient-focused approaches. We are a privately-owned company situated in Oakland, California, and proudly handle all aspects of product design, development, and manufacturing.

www.koyamedical.com LinkedIn Oakland, United States 51-100 employees
Biotechnology Health Care Internet Pharmaceutical B2C
Total raised
$30.0M
Rounds
1
Latest
Undisclosed round
Nov 2023

Koya Medical has raised $30.0M across 1 funding round on record, the most recent an undisclosed round of $30.0M announced in Nov 2023.

That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Koya Medical Company Profile and Key Stats

Total funding raised
$30.0M
across 1 round on record
Funding rounds on record
1
Latest funding round
Undisclosed round
$30.0M in Nov 2023
Employees
51-100
reported band
Headquarters
Oakland, United States

Latest funding round on record: Nov 2023.

Koya Medical Funding Rounds

Date
Round
Amount
Undisclosed round
$30.0M

Koya Medical Founders and Leadership Team

Name
Role
Contact
Andy Doraiswamy
CEO

No contact details are on record for this team yet.

Koya Medical Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,179
$8.0M
29,722
$7.5M

Koya Medical's latest round of $30.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Koya Medical in Biotechnology and Oakland

Companies Similar to Koya Medical

Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…

Convertible Note $6.8M

XiltriX North America is an information technology company that specializes in monitoring, predictive…

Undisclosed round $3.0M

Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…

Seed $3.1M

Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…

Series D $66.0M

Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…

Series B $92.7M

Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…

Series C $110M

InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…

Series B $77.0M

Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…

Series A $6.3M

Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.

Series C $90.0M

Cataract surgery is the single most common procedure performed in the United States annually. Despite…

Series A $7.0M

InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…

Convertible Note $1.3M

Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…

Series A $10.0M

Koya Medical Funding FAQs

What does Koya Medical do?

Koya Medical is an innovative healthcare organization dedicated to advancing the treatment of venous and lymphatic diseases. By offering revolutionary therapies, we aim to enhance movement, mobility, and personalized care, surpassing what traditional compression therapy can provide. Established in 2018, Koya is committed to revolutionizing venous and lymphatic care through patient-focused approaches. We are a privately-owned company situated in Oakland, California, and proudly handle all aspects of product design, development, and manufacturing.

How much funding has Koya Medical raised?

Koya Medical has raised $30.0M across 1 round on record. The most recent is an undisclosed round of $30.0M announced in Nov 2023.

When did Koya Medical last raise funding?

Koya Medical's most recent funding round on record is an undisclosed round of $30.0M, announced in Nov 2023.

Who is the CEO of Koya Medical?

Andy Doraiswamy is listed as CEO at Koya Medical.

Where is Koya Medical headquartered?

Koya Medical is based in Oakland, California, United States.

How many employees does Koya Medical have?

Koya Medical is in the 51-100 employee band.

How does Koya Medical's funding compare to other Biotechnology startups?

Koya Medical's latest round of $30.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.

About FundedIQ's Koya Medical Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Koya Medical is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.